Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
PUT
General Mills
GIS
$21.9B
| $25.6M | 0.01% |
400,500
+166,200
| +71% | +$11.6M |
|
852
CALL
Genuine Parts
GPC
$18.7B
| $25.5M | 0.01% |
254,300
+109,500
| +76% | +$11.1M |
|
853
CALL
ServiceNow
NOW
$132B
| $25.5M | 0.01% |
1,612,000
+241,000
| +18% | +$3.55M |
|
854
PUT
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.82B
| $25.5M | 0.01% |
1,050,000
-1,027,200
| -49% | -$24.8M |
|
|
DATA
855
CALL
DELISTED
Tableau Software, Inc.
DATA
| $25.5M | 0.01% |
461,400
+15,000
| +3% | +$826K |
|
856
CALL
Travelers Companies
TRV
$77.3B
| $25.4M | 0.01% |
221,800
+27,900
| +14% | +$3.27M |
|
857
Ulta Beauty
ULTA
$23.2B
| $25.4M | 0.01% |
106,699
+77,465
| +265% | +$19.6M |
|
858
PUT
CME Group
CME
$100B
| $25.3M | 0.01% |
242,300
-25,100
| -9% | -$2.62M |
|
859
CALL
Lincoln National
LNC
$8.11B
| $25.2M | 0.01% |
537,000
+169,300
| +46% | +$7.58M |
|
860
CALL
F5
FFIV
$21.5B
| $25.2M | 0.01% |
202,400
-72,400
| -26% | -$8.79M |
|
|
CXO
861
CALL
DELISTED
CONCHO RESOURCES INC.
CXO
| $25.2M | 0.01% |
183,400
+10,000
| +6% | +$1.27M |
|
862
CALL
Zoetis
ZTS
$31.9B
| $25.2M | 0.01% |
483,900
+36,300
| +8% | +$1.84M |
|
863
CALL
Vale
VALE
$64B
| $25.1M | 0.01% |
4,558,600
+225,500
| +5% | +$1.24M |
|
864
CALL
GameStop
GME
$8.09B
| $25M | 0.01% |
3,623,600
-144,800
| -4% | -$1.06M |
|
865
CALL
Cracker Barrel
CBRL
$1.3B
| $25M | 0.01% |
188,900
+98,300
| +108% | +$15.1M |
|
866
CALL
Akamai
AKAM
$15.2B
| $25M | 0.01% |
471,100
+57,200
| +14% | +$3.06M |
|
867
PUT
Core Laboratories
CLB
$553M
| $24.9M | 0.01% |
222,000
+97,200
| +78% | +$11.2M |
|
868
Viatris
VTRS
$19B
| $24.7M | 0.01% |
649,075
+317,373
| +96% | +$14.1M |
|
|
HZNP
869
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $24.7M | 0.01% |
1,360,100
+233,100
| +21% | +$4.55M |
|
870
PUT
Qorvo
QRVO
$8.41B
| $24.6M | 0.01% |
441,500
+260,100
| +143% | +$14.8M |
|
871
CALL
Ecolab
ECL
$80.4B
| $24.6M | 0.01% |
202,100
-104,100
| -34% | -$12.6M |
|
|
JOYY
872
JOYY Inc
JOYY
$3.7B
| $24.6M | 0.01% |
460,973
-4,601
| -1% | -$210K |
|
873
GoPro
GPRO
$111M
| $24.4M | 0.01% |
1,464,524
-133,709
| -8% | -$1.84M |
|
874
PUT
ProShares Ultra S&P500
SSO
$8.36B
| $24.4M | 0.01% |
2,752,800
-637,600
| -19% | -$5.62M |
|
|
RTN
875
PUT
DELISTED
Raytheon Company
RTN
| $24.4M | 0.01% |
178,900
+62,000
| +53% | +$8.62M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.